ABOUT US  |  CONTACT US  |  RSS  |  ARCHIVE  |  2021-01-23  |  UPDATED: 1399/11/01 - 11:25:4 FA | AR | PS | EN
Tumultuous Trump era comes to an end            Italyís government survives crucial senate confidence vote            Russia will not take into account Westís calls to release Navalny             UK military puts earnings before ethics             Trump told associates he wants to start íPatriot Partyí: WSJ            FM Zarif welcomes Qatarís call for Persian Gulf states to begin talks with Iran            US surpasses 400,000 coronavirus deaths            US should rejoin Iran nuclear deal with no preconditions: China             Concerns grow about extremists infiltration into US national Guard ahead of Biden inauguration             6 Policemen Wounded in Herat IED Blast             Afghan Govt Will Not Release More Taliban Prisoners: Omar             US inauguration week begins amid wartime conditions             UN chief urges pullout of foreign forces from Libya            Germany regrets US plan to ban Russian vessel over Nord Stream 2 project             Pentagon deploys troops skilled in handling nukes for Bidenís inauguration            


DATE PUBLISHED: 2017/10/5 - 12:48:45
VISIT: 3590
SHARE WITH YOUR FRIENDS

Europeís cancer drugs mostly ineffective: Study
 Europeís cancer drugs mostly ineffective: Study

European regulators approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked better than existing medicines, or at all, researchers said Thursday.

The number represented more than half of 68 treatments to become available for European cancer patients during this period, they said, "raising serious questions about the current standards of drug regulation."

Apart from dashing patient hopes, allowing unproven medicine onto the market also unnecessarily exposed people to toxicity inherent in all drugs, while inflating state pharmaceutical spending.

Writing in The BMJ medical journal, a team of public health experts expressed concern about the approval of often-pricey new cancer drugs by the EU regulator, the European Medicines Agency (EMA).

"This situation has negative implications for patients and public health," they warned.

"When expensive drugs that lack clinically meaningful benefits are approved and paid for within publicly funded healthcare systems, individual patients can be harmed, important societal resources wasted, and the delivery of equitable and affordable care undermined."

Many drugs were approved on the basis of inconclusive, early test results such as lab experiments, which were unable to predict whether they would actually make a patient feel better or live longer.

Another study, published in 2015, had found that most cancer drugs approved by the US Food and Drug Administration (FDA) between 2008 and 2012 similarly came with no evidence that they boosted patient survival or improved quality of life.

One of the authors of the American study, Vinay Prasad from the Oregon Health & Science University, pointed out that the average cancer drug in the US costs more than $100,000 (85,000 euros) per person per year.

"In the US, this broken system means huge expenditures on cancer drugs with certain toxicity but uncertain benefit," he wrote in a comment also carried by The BMJ.

"The US Medicare program is legally required to pay for any drug approved by the FDA without negotiation on price."

Given the toxicity and expense of cancer drugs, patients should be exposed only "when they can reasonably expect an improvement in survival or quality of life," said Prasad.

The new study found that 11 new drugs approved by the EMA between 2009 and 2013 were not shown to work any better than existing medicines to which they were compared, co-author Courtney Davis of Kingís College London told AFP.

In the case of 20 drugs, they worked no better than a placebo or "dummy" drug, and another eight were not compared to anything at all, "so we donít know whether they extend or improve life," she said.

 

LINK: https://www.ansarpress.com/english/9040






*
*

*



SEE ALSO

Miami Doctor Dies After Getting Pfizer COVID-19 Vaccine, Reports Say


Iranian and Afghan medical universities sign MoU to strengthen relations


British coronavirus vaccine: Human trials to include 10,000


Oxford-based pharmatech company uses artificial intelligence to find drug against COVID-19


Coronavirus: WHO warns against íimmunity passportsí for recovered patients


US Open likely to be played in front of fans despite COVID-19 outbreak


Iran ramps up production of coronavirus test kits


Herat Lab Lacks COVID-19 Test Kits


A UK consortium hopes to soon be making at least 1,500 ventilators a week


Loss of taste and smell key COVID-19 symptoms, app study finds





VIEWED
MOST DISCUSSED




POLL

Modi, Merkel Discuss Afghanistan, Radicalisation And Terrorism

SEE RESULT


LAST NEWS

Incoming top US intelligence official vows to release report on Khashoggi murder

Tumultuous Trump era comes to an end

Italyís government survives crucial senate confidence vote

Russia will not take into account Westís calls to release Navalny

UK military puts earnings before ethics

Trump told associates he wants to start íPatriot Partyí: WSJ

FM Zarif welcomes Qatarís call for Persian Gulf states to begin talks with Iran

US surpasses 400,000 coronavirus deaths

US should rejoin Iran nuclear deal with no preconditions: China

Concerns grow about extremists infiltration into US national Guard ahead of Biden inauguration

6 Policemen Wounded in Herat IED Blast

Afghan Govt Will Not Release More Taliban Prisoners: Omar

US inauguration week begins amid wartime conditions

UN chief urges pullout of foreign forces from Libya

Germany regrets US plan to ban Russian vessel over Nord Stream 2 project

Pentagon deploys troops skilled in handling nukes for Bidenís inauguration

EX-AG called Trump fraud claim íbulls---í to his face

Iranian Armyís Ground Force starts drill on southeastern Makran coast

Elections planned for summer, including Ghazni poll

Taliban ambush security checkpoint in Badakhshan

Aftershock rocks Indonesia quake zone as search for survivors continues

Lady Fatimah Zahra (S.A), after demise of Prophet Muhammad (PBUH)

Fatimah (S.A), daughter of Prophet Muhammad (A.S) and Lady Khadija (S.A)

Turkey to continue talks with Russia on 2nd batch of S-400 air defense systems: Erdogan

Russia: Iran is ívictim of terrorismí, among ípioneersí in fight against terror

US warns India against S-400 purchase deal with Russia: Report

Tunisian protesters, security forces clash after police beating of shepherd

US murder increase in 2020 triples previous annual record

IRGCís missiles destroy mock enemy warships 1,800 kilometers away during drills

Cuba blasts US sanctions on interior ministry as Ďcoercive measureí

WhatsApp postpones data-sharing change after backlash

Parliament rejects draft budget for second time

Bamiyan youth take to the slopes in first skiing contest of the season

Two police personnel killed in targeted explosion in Kabul

12 local police killed in Taliban attack in Herat

House votes to impeach Donald Trump with just a week to go before he is due to step down

Johnson triggers diplomatic row with China by blaming it for coronavirus pandemic

Iran says US blacklisting of Yemenís Ansarullah will kill political process, talks

People plotting to do danger: US senator

Absolutely groundless: Russia rejects US claim of Iran-Qaeda ties


MEDICAL NEWS


ANSAR PRESS ©  |  ABOUT US  |  CONTACT US  |  MOBILE VERSION  |  LINKS  |  DESIGN: Negah Network Co.
All right reserved. Use this website by mentioning the source (link) is allowed. ›—ś‘ź«Ś «یš —š ی šŕŠ»šŌ«š